Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid.
Ontology highlight
ABSTRACT: Metagenomic next-generation sequencing (mNGS) for pan-pathogen detection has been successfully tested in proof-of-concept case studies in patients with acute illness of unknown etiology but to date has been largely confined to research settings. Here, we developed and validated a clinical mNGS assay for diagnosis of infectious causes of meningitis and encephalitis from cerebrospinal fluid (CSF) in a licensed microbiology laboratory. A customized bioinformatics pipeline, SURPI+, was developed to rapidly analyze mNGS data, generate an automated summary of detected pathogens, and provide a graphical user interface for evaluating and interpreting results. We established quality metrics, threshold values, and limits of detection of 0.2-313 genomic copies or colony forming units per milliliter f
SUBMITTER: Miller S
PROVIDER: S-EPMC6499319 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
ACCESS DATA